ArticleIndian journal of ophthalmology2021

One-year outcomes of Aflibercept for refractory diabetic macular edema in Bevacizumab nonresponders.

Ali Salimi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.